BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9633515)

  • 21. EGF receptor activation decreases retroviral gene transfer through protein kinase C-delta.
    Singh R; Andreadis ST
    Mol Ther; 2007 Feb; 15(2):369-77. PubMed ID: 17235316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ErbB4 (JM-b/CYT-1)-induced expression and phosphorylation of c-Jun is abrogated by human papillomavirus type 16 E5 protein.
    Chen SL; Lin ST; Tsai TC; Hsiao WC; Tsao YP
    Oncogene; 2007 Jan; 26(1):42-53. PubMed ID: 16819515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transformation-specific interaction of the bovine papillomavirus E5 oncoprotein with the platelet-derived growth factor receptor transmembrane domain and the epidermal growth factor receptor cytoplasmic domain.
    Cohen BD; Goldstein DJ; Rutledge L; Vass WC; Lowy DR; Schlegel R; Schiller JT
    J Virol; 1993 Sep; 67(9):5303-11. PubMed ID: 8394451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the influences of the E5 transforming protein on kinetic parameters of epidermal growth factor binding and metabolism.
    Waters CM; Overholser KA; Sorkin A; Carpenter G
    J Cell Physiol; 1992 Aug; 152(2):253-63. PubMed ID: 1639860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4.
    Komurasaki T; Toyoda H; Uchida D; Morimoto S
    Oncogene; 1997 Dec; 15(23):2841-8. PubMed ID: 9419975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of human papillomavirus 16 E5 to the 16 kDa subunit c (proteolipid) of the vacuolar H+-ATPase can be dissociated from the E5-mediated epidermal growth factor receptor overactivation.
    Rodríguez MI; Finbow ME; Alonso A
    Oncogene; 2000 Aug; 19(33):3727-32. PubMed ID: 10949926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endocytosis deficiency of epidermal growth factor (EGF) receptor-ErbB2 heterodimers in response to EGF stimulation.
    Wang Z; Zhang L; Yeung TK; Chen X
    Mol Biol Cell; 1999 May; 10(5):1621-36. PubMed ID: 10233167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. E5 protein of human papillomavirus type 16 protects human foreskin keratinocytes from UV B-irradiation-induced apoptosis.
    Zhang B; Spandau DF; Roman A
    J Virol; 2002 Jan; 76(1):220-31. PubMed ID: 11739687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer.
    Karunagaran D; Tzahar E; Beerli RR; Chen X; Graus-Porta D; Ratzkin BJ; Seger R; Hynes NE; Yarden Y
    EMBO J; 1996 Jan; 15(2):254-64. PubMed ID: 8617201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The human papillomavirus type 16 E5 oncoprotein inhibits epidermal growth factor trafficking independently of endosome acidification.
    Suprynowicz FA; Krawczyk E; Hebert JD; Sudarshan SR; Simic V; Kamonjoh CM; Schlegel R
    J Virol; 2010 Oct; 84(20):10619-29. PubMed ID: 20686024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ErbB/HER family of protein-tyrosine kinases and cancer.
    Roskoski R
    Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The bovine papillomavirus E5 transforming protein can stimulate the transforming activity of EGF and CSF-1 receptors.
    Martin P; Vass WC; Schiller JT; Lowy DR; Velu TJ
    Cell; 1989 Oct; 59(1):21-32. PubMed ID: 2551505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
    Motoyama AB; Hynes NE; Lane HA
    Cancer Res; 2002 Jun; 62(11):3151-8. PubMed ID: 12036928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EGF activates ErbB-2 and stimulates phosphatidylinositol 3-kinase in human airway smooth muscle cells.
    Krymskaya VP; Hoffman R; Eszterhas A; Kane S; Ciocca V; Panettieri RA
    Am J Physiol; 1999 Feb; 276(2):L246-55. PubMed ID: 9950886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor.
    Pim D; Collins M; Banks L
    Oncogene; 1992 Jan; 7(1):27-32. PubMed ID: 1311063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen-independent activation of erbBs signaling and estrogen receptor alpha in the mouse vagina exposed neonatally to diethylstilbestrol.
    Miyagawa S; Katsu Y; Watanabe H; Iguchi T
    Oncogene; 2004 Jan; 23(2):340-9. PubMed ID: 14647453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of cell transformation by papillomavirus E5 proteins.
    DiMaio D; Mattoon D
    Oncogene; 2001 Nov; 20(54):7866-73. PubMed ID: 11753669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross talk between c-Met and epidermal growth factor receptor during retinal pigment epithelial wound healing.
    Xu KP; Yu FS
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2242-8. PubMed ID: 17460286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.
    Kokai Y; Dobashi K; Weiner DB; Myers JN; Nowell PC; Greene MI
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5389-93. PubMed ID: 2899889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neu differentiation factor/heregulin modulates growth and differentiation of HC11 mammary epithelial cells.
    Marte BM; Jeschke M; Graus-Porta D; Taverna D; Hofer P; Groner B; Yarden Y; Hynes NE
    Mol Endocrinol; 1995 Jan; 9(1):14-23. PubMed ID: 7760847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.